Skip to main content

Advertisement

Log in

Retrospective study of post-anesthetic mild liver disorder associated with inhalation anesthetics, halothane and enflurane

  • Original Articles
  • Published:
Journal of Anesthesia Aims and scope Submit manuscript

Abstract

The incidence of post-anesthetic mild liver disorder (PAMLD) was compared between 928 patients administered halothane and 1,766 patients administered enflurane. They were selected from 19,504 surgical patients administered general anesthesia at Kyushu University Hospital over the past 6 years and 4 months. They had had normal liver function before operation and had no history of blood transfusion. Alanine aminotransferase (ALT) levels exceeding 70 IU·l −1 within 180 days after operation were found in 226 patients in the halothane group (24.4%), and in 250 patients in the enflurane group (14.2%) (P<0.01). Both maximum ALT levels and duration of ALT elevation were higher and longer in the halothane group (P<0.01). These results suggest that, not only in the development of fulminant hepatitis but also in PAMLD, enflurane is less hepatotoxic than halothane.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. 1. Subcommittee on the National Halothane Study of the committee on Anesthesia National Academy of Science-National Research Council: Summary of the National Halothane Study. JAMA 197:775–778, 1966

    Article  Google Scholar 

  2. Lewis JH, Zimmerman HJ, Ishak KJ, et al: Enflurane hepatotoxicity, A clinicopathologic study of 24 cases. Ann Internal Med 98:984–992, 1983

    CAS  Google Scholar 

  3. Inman WHW, Mushin WW: Jaundice after repeated exposure to halothane: An analysis of reports to the Committee on Safety of Medicines. Brit Med J 1:5–10, 1974

    Article  CAS  PubMed  Google Scholar 

  4. DeBacker LJ, Longnecker DS: Prospective and retrospective searches for liver necrosis following halothane anesthesia. JAMA 195:95–160, 1066

    Google Scholar 

  5. Mushin WW, Rosen M, Bowen DJ, et al: Halothane and liver dysfunction: a retrospective study. Brit med J 2:329–341, 1964

    Article  CAS  PubMed  Google Scholar 

  6. Böttiger LE, Dalén E, Hallén B: Halothane-induced liver damage: An analysis of the material reported to the Swedish Adverse Drug Reaction Committee, 1966–1973. Acta Anaesth Scand 20:40–46, 1976

    Article  PubMed  Google Scholar 

  7. Stock JGL, Strunin L: Unexplained hepatitis following halothane. [review article]. Anesthesiology 63:424–439, 1985

    Article  CAS  PubMed  Google Scholar 

  8. Brown MB: Two-way and multi-way frequency tables, BMDP Statistical Software. Edited by Dixon WJ. Berkeley, University California Press, 1985, pp. 143–206

    Google Scholar 

  9. Wright R, Eade OE, Chisholm M, et al: Controlled prospective study of the effect on liver function of multiple exposures to halothane. Lancet 12:817–820, 1975

    Article  Google Scholar 

  10. Trowell J, Peto R, Smith AC: Controlled trial of repeated halothane anaesthetics in patients with carcinoma of the uterine cervix treated with radium. Lancet 12:821–823, 1975

    Google Scholar 

  11. Kalow B, Rogoman E, Sims FH: A comparison of the effects halothane and other anaesthetic agents on hepato-cellular function in patients submitted to elective operations. Canad Anaesth Soc J 23:71–79, 1976

    Article  CAS  PubMed  Google Scholar 

  12. McEwan J: Liver function tests following anaesthesia. Br J Anaesth 48:1065–1069, 1976

    Article  CAS  PubMed  Google Scholar 

  13. Cousins MJ, Plummer JL, Hall PM: Risk factors for halothane hepatitis. [review article]. Aust N Z J Surg 59:5–14, 1989

    Article  CAS  PubMed  Google Scholar 

  14. Allen PJ, Downing JW: A prospective study of hepatocellular function after repeated exposures to halothane or enflurane in women undergoing radium therapy for cervical cancer. Br J Anaesth 49:1035–1034, 1977

    Article  CAS  PubMed  Google Scholar 

  15. Thompson DS, Friday DD, Rock L: Changes in liver enzyme values after halothane and enflurane for surgical anesthesia. South Med J 71(7):779–782, 1978

    CAS  PubMed  Google Scholar 

  16. Johnston SB, Fee JPH, Black GW, et al: Liver funciton following repeated anaesthesia method of study and interim results. Acta Anaesth Scand Suppl. 71:12–14, 1979

    Article  CAS  Google Scholar 

  17. Fee JPH, Black GW, Dundee JW, et al: Prospective study of liver enzyme and other changes following repeat administration of halothane and enflurane. Br J Anaesth 51:1133–1141, 1979

    Article  CAS  PubMed  Google Scholar 

  18. Cousins MJ, Gourlay GK, Knights KM, et al: A randomized prospective controlled study of the metabolism and hepatotoxicity of halothane in humans. Anesth Analg 66:299–308, 1987

    CAS  PubMed  Google Scholar 

  19. Neuberger J, Kenna JG: Halothane hepatitis: A model of immune mediated drug hepatotoxicity. Clinical Science 72:263–270, 1987

    CAS  PubMed  Google Scholar 

  20. Kenna JG, Neuberger, J, Williams R: Identification by immunoblotting of three halothane-induced liver microsomal polypeptide antigens recognized by antibodies in sera from patients with halothane-associated hepatitis. J Pharmacol Exp Ther 242:733–740, 1987

    CAS  PubMed  Google Scholar 

  21. Kenna JG, Satoh H, Christ DD, et al: Metabolic basis for a drug hypersensitivity: antibodies in sera from patients with halothane hepatitis recognize liver neoantigens that contain the trifluoroacetyl group derived from halothane. J Phamacol Exp Ther 245:1103–1109, 1988

    CAS  Google Scholar 

  22. Kenna JG, Neuberger J, Williams R: Evidence for expression in human liver of halothane-induced neoantigens recognized by antibodies in sera from patients with halothane hepatitis. Hepatology 8:1635–1541, 1988

    Article  CAS  PubMed  Google Scholar 

  23. Christ DD, Kenna JG, Kammerer W, et al: Enflurane metabolism produces covalentry bound liver adducts recognized by antibodies from patients with halothane hepatitis. Anesthesiology 69:833–838, 1988

    Article  CAS  PubMed  Google Scholar 

  24. Satoh H, Martin BM, Schulick AH, et al: Human anti-endoplasmic reticulum antibodies in sera of patients with halothane-induced hepatitis are directed against a trifluoroacetylated carboxylesterase. Proc Natl Acad Sci USA 86:322–326, 1989

    Article  CAS  PubMed  Google Scholar 

  25. Berman ML, Holaday DA: Inhalation anaesthetic metabolism and toxicity, CLINICAL ANESTHESIA. Edited by Barash PG, Cullen BF, Stoelting RK. Philadelphia, J.B. Lippincott, 1989, pp326

    Google Scholar 

  26. McLain GE, Sipes G, Brown BR: An animal model of halothane hepatotoxicity: Roles of enzyme induction and hypoxia. Anesthesiology 51:321–326, 1979

    Article  CAS  PubMed  Google Scholar 

  27. Plummer JL, Beckwith ALJ, Bastin FN, et al: Free radical formation in vivo and hepatotoxicity due to anesthesisa with halothane. Anesthesiology 57:160–166, 1982

    Article  CAS  PubMed  Google Scholar 

  28. Hughes RL, Campbell D, Fitch W: Effects of enflurane and halothane on liver blood flow and oxygen consumption in the Greyhound. Br J Anaesth 52:1079–1086, 1980

    Article  CAS  PubMed  Google Scholar 

  29. Shingu K, Eger EI, Johnson BH: Hypoxia may be more important than reductive metabolism in halothane-induced hepatic injury. Anesth Analg 61:824–827, 1982

    CAS  PubMed  Google Scholar 

  30. Gelman S: Halothane hepatotoxicity-again? [editorial]. Anesth Analg 65:831–834, 1986

    CAS  PubMed  Google Scholar 

  31. Shieble T, Costa A, Heffel D, et al: Comparative toxicity of halothane, isoflurane, hypoxia, and phenobarbital induction in monolayer cultures of rat hepatocytes. Anesthesiology 68:485–494, 1988

    Article  Google Scholar 

  32. Stoelting RK, Blitt CD, Cohen PJ, et al: Hepatic dysfunction after isoflurane anesthesia. Anesth Analg 66:147–153, 1987

    Article  CAS  PubMed  Google Scholar 

  33. Gelman S, Flowler KC, Smith LR: Regional blood flow during isoflurane and halothane anesthesia. Anesth Analg 63:557–565, 1984

    CAS  PubMed  Google Scholar 

  34. Gelman S, Dillard E, Bradley EL: Hepatic circulation during surgical stress and anesthesia with halothane, isoflurane, or fentanyl. Anesth Analg 66:936–943, 1987

    Article  CAS  PubMed  Google Scholar 

  35. Nagagano K, Gelman S, Parks D, et al: Hepatic circulation and oxygen. uptake relationships after hepatic ischemic insult during anesthesia with volatile anesthetics and fentanyl in miniature pigs. Anesth Analg 70:53–62, 1990

    Article  Google Scholar 

  36. Nöldge GFE, Priebe HJ, Kopp KH, et al: Differences in effects of isoflurane and enflurane on splanchnic oxygenation and hepatic metabolism in the pig. Anesth Analg 71:258–267, 1990

    PubMed  Google Scholar 

  37. Goldfarb G, Debaene B, Ang ET, et al: Hepatic blood flow in humans during isofturane-N2O and halothane-N2O Anesthesia. Anesth Analg 71:349–353, 1990

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

About this article

Cite this article

Sakaguchi, Y., Inaba, S., Umeki, Y. et al. Retrospective study of post-anesthetic mild liver disorder associated with inhalation anesthetics, halothane and enflurane. J Anesth 6, 183–191 (1992). https://doi.org/10.1007/s0054020060183

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s0054020060183

Key words

Navigation